{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:36:56Z","timestamp":1759412216721,"version":"3.37.3"},"reference-count":69,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"sponsored by Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2019,11,2]]},"DOI":"10.1080\/21645515.2019.1596711","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T14:35:21Z","timestamp":1554129321000},"page":"2729-2737","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["A physician\u2019s guide to the 2-dose schedule of MenB-FHbp vaccine"],"prefix":"10.1080","volume":"15","author":[{"given":"Angee","family":"McDaniel","sequence":"first","affiliation":[{"name":"Medical Development, Scientific & Clinical Affairs, Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7085-6259","authenticated-orcid":false,"given":"Amanda","family":"Dempsey","sequence":"additional","affiliation":[{"name":"University of Colorado Denver, Anschutz Medical Campus, Denver, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2510-5058","authenticated-orcid":false,"given":"Amit","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Medical Development, Scientific & Clinical Affairs, Pfizer Vaccines, Pfizer Inc, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"issue":"2","key":"CIT0001","first-page":"1","volume":"62","author":"Cohn AC","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"CIT0002","first-page":"608","volume":"64","author":"Folaranmi T","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"CIT0003","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2016 [accessed 2018 Sept 26]. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2130"},{"volume-title":"Full prescribing information","year":"2017","author":"Trumenba\u00ae (meningococcal group B vaccine)","key":"CIT0005"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"CIT0008","unstructured":"World Health Organization. Meningococcal meningitis. [accessed 2018 Sept 26]. http:\/\/www.who.int\/immunization\/diseases\/meningitis\/en\/."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"CIT0010","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2017 [accessed 2018 Nov 30]. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2017.pdf."},{"key":"CIT0011","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2015 [accessed 2018 June 19]. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2015.pdf."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"CIT0013","unstructured":"Meyer S. Epidemiology of meningococcal disease among college students \u2013 United States, 2014-2016 [accessed 2018 Apr 2]. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2018-02\/Mening-02-Meyer-508.pdf."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6520a3"},{"key":"CIT0015","unstructured":"Meyer S. Update on the epidemiology of meningococcal disease and guidance for the control of meningococcal disease outbreaks in the U.S. [accessed 2018 Sept 26]. https:\/\/pdfs.semanticscholar.org\/presentation\/e0b3\/aa069eb91e1d831b8c40d4340d21afa4c513.pdf."},{"volume-title":"Update: invasive meningococcal cases at the University of Massachusetts (UMass) Amherst","year":"2017","author":"De Maria A","key":"CIT0016"},{"volume-title":"Invasive meningococcal disease outbreak at San Diego State University","year":"2018","author":"California Health Alert Network San Diego","key":"CIT0017"},{"volume-title":"Full prescribing information","year":"2016","author":"Menactra\u00ae (meningococcal [groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine)","key":"CIT0018"},{"volume-title":"Full prescribing information","year":"2017","author":"Menveo\u00ae (meningococcal [groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine)","key":"CIT0019"},{"volume-title":"Summary of product characteristics","year":"2017","author":"NIMENRIX (meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine)","key":"CIT0020"},{"key":"CIT0021","unstructured":"Bexsero (MenB-4C). Summary of product characteristics. Siena (Italy): GlaxoSmithKline Vaccines Srl. 2018."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6543a3"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00056-12"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1264750"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.8.970-976.2005"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.091"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-35761-6.00053-5"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614474"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00036-18"},{"key":"CIT0034","unstructured":"European Medicines Agency. Assessment report: Trumenba [accessed 2017 July 7]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/004051\/WC500228997.pdf."},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1483726"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv064"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001124"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001072"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv039"},{"key":"CIT0040","unstructured":"Study B1971012 Data on File. New York (NY): Pfizer Inc; 2013."},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00034-17"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.016"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001399"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.066"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00121-17"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.092"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00261-17"},{"volume-title":"Full prescribing information","year":"2018","author":"Bexsero (meningococcal group B vaccine)","key":"CIT0049"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.103"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.001"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61713-3"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1177\/2051013616681365"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514866"},{"volume-title":"Paper presented at: International Pathogenic Neisseria Conference","year":"2018","author":"Basta N","key":"CIT0055"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31921-3"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2018.01.002"},{"key":"CIT0058","unstructured":"C.S. Mott Children\u2019s Hospital, National Poll on Children\u2019s Health. Parents not keeping up with teen vaccines [accessed 2018 September 26]. http:\/\/mottpoll.org\/reports-surveys\/parents-not-keeping-teen-vaccines."},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2018.04.005"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3484"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0344"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-1633"},{"volume-title":"Paper presented at: IDWeek","year":"2018","author":"Huang L","key":"CIT0063"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6733a1"},{"key":"CIT0065","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2018 [accessed 2018 Sept 26]. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html."},{"key":"CIT0066","unstructured":"Adolescent Immunization Initiative. Rationale for an immunization platform at 16 years of age [accessed 2018 June 14]. https:\/\/www.give2mcv4.org\/content\/uploads\/2017\/03\/rationale-for-16-year-old-immunization-platform.pdf."},{"key":"CIT0067","unstructured":"Atkinson W, Immunization Action Coalition. Adolescent immunization update and the 16-year-old platform [accessed 2018 Sept 26]. www.immunize.org\/catg.d\/S8005.pdf."},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2017.01.011"},{"key":"CIT0069","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2017 [accessed 2018 Jan 9]. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1596711","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1596711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T12:35:23Z","timestamp":1608640523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1596711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,2]]}},"alternative-id":["10.1080\/21645515.2019.1596711"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1596711","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"type":"print","value":"2164-5515"},{"type":"electronic","value":"2164-554X"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}